18 results on '"West, Imara I"'
Search Results
2. Health plan‐based mailed fecal testing for colorectal cancer screening among dual‐eligible Medicaid/Medicare enrollees: Outcomes of 2 program models.
- Author
-
Baldwin, Laura‐Mae, Coronado, Gloria D., West, Imara I., Schwartz, Malaika R., Meenan, Richard T., Vollmer, William M., Petrik, Amanda F., Shapiro, Jean A., Kulkarni‐Sharma, Yogini R., and Green, Beverly B.
- Subjects
EARLY detection of cancer ,MEDICAID ,MEDICARE ,HEALTH insurance ,MEDICAL screening - Abstract
Background: Health insurance plans are increasingly offering mailed fecal immunochemical test (FIT) programs for colorectal cancer (CRC) screening, but few studies have compared the outcomes of different program models (eg, invitation strategies). Methods: This study compares the outcomes of 2 health plan–based mailed FIT program models. In the first program (2016), FIT kits were mailed to all eligible enrollees; in the second program (2018), FIT kits were mailed only to enrollees who opted in after an outreach phone call. Participants in this observational study included dual‐eligible Medicaid/Medicare enrollees who were aged 50 to 75 years and were due for CRC screening (1799 in 2016 and 1906 in 2018). Six‐month FIT completion rates, implementation outcomes (eg, mailed FITs sent and reminders attempted), and program‐related health plan costs for each program are described. Results: All 1799 individuals in 2016 were sent an introductory letter and a FIT kit. In 2018, all 1906 were sent an introductory letter, and 1905 received at least 1 opt‐in call attempt, with 410 (21.5%) sent a FIT. The FIT completion rate was 16.2% (292 of 1799 [95% CI, 14.5%‐17.9%]) in 2016 and 14.6% (278 of 1906 [95% CI, 13.0%‐16.2%]) in 2018 (P =.36). The overall implementation costs were higher in 2016 ($40,156) than 2018 ($34,899), with the cost per completed FIT slightly higher in 2016 ($138) than 2018 ($126). Conclusions: An opt‐in mailed FIT program achieved FIT completion rates similar to those of a program mailing to all dual‐eligible Medicaid/Medicare enrollees. Lay Summary: Health insurance plans can use different program models to successfully mail fecal test kits for colorectal cancer screening to dual‐eligible Medicaid/Medicare enrollees, with nearly 1 in 6 enrollees completing fecal testing. In this study, a health insurance plan demonstrates its ability to deliver 2 different mailed fecal immunochemical test (FIT) program models, with vendors used to manage some program elements. These mailed FIT programs began to close gaps in colorectal cancer screening rates in the health plan's dual‐eligible Medicaid/Medicare population. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Costs of Two Health Insurance Plan Programs to Mail Fecal Immunochemical Tests to Medicare and Medicaid Plan Members.
- Author
-
Meenan, Richard T., Baldwin, Laura-Mae, Coronado, Gloria D., Schwartz, Malaika, Coury, Jennifer, Petrik, Amanda F., West, Imara I., and Green, Beverly B.
- Subjects
HEALTH insurance & economics ,FECAL analysis ,INSURANCE companies ,SCIENTIFIC observation ,MEDICAL care costs ,HUMAN services programs ,STATE health plans ,POSTAL service ,COST analysis ,DESCRIPTIVE statistics ,RESEARCH funding ,MEDICAID ,ECONOMIC aspects of diseases ,MEDICARE - Abstract
BeneFIT is a 4-year observational study of a mailed fecal immunochemical test (FIT) program in 2 Medicaid/Medicare health plans in Oregon and Washington. In Health Plan Oregon's (HPO) collaborative model, HPO mails FITs that enrollees return to their clinics for processing. In Health Plan Washington's (HPW) centralized model, FITs are mailed directly to enrollees who return them to a centralized laboratory. This paper examines model-specific Year 1 development and implementation costs and estimates costs per screened enrollee. Staff completed activity-based costing spreadsheets. Non-labor costs were from study and external data. Data matched each plan's 2016 development and implementation dates. HPO development costs were $23.0K, primarily administration (eg, clinic recruitment). HPW development costs were $37.3K, 38.8% for FIT selection and mailing/tracking protocols. Year 1 implementation costs were $51.6K for HPO and $139.7K for HPW, reflecting HPW's greater outreach. Labor was 50.4% ($26.0K) of HPO's implementation costs, primarily enrollee eligibility and processing returned FITs, and was shared by HPO ($17.0K) and 6 participating clinics ($9.0K). Labor was 10.5% of HPW's implementation costs, primarily administration and enrollee eligibility. HPO's implementation costs per enrollee were 12.3% higher ($18.36) than for HPW ($16.34). Similar proportions of completed FITs among screening-eligibles produced a 15% lower cost per completed FIT in HPW ($89.75) vs. HPO ($105.79). Implementation costs for HPO only (without clinic costs) were $15.16/mailed introductory letter, $16.09/mailed FIT, and $87.35/completed FIT, comparable to HPW. Results highlight cost implications of different approaches to implementing a mailed FIT program in 2 Medicaid/Medicare health plans. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. Challenges in Reaching Medicaid and Medicare Enrollees in a Mailed Fecal Immunochemical Test Program.
- Author
-
Green, Beverly B., West, Imara I., Baldwin, Laura Mae, Schwartz, Malaika R., Coury, Jennifer, and Coronado, Gloria D.
- Subjects
COLON tumors ,FECAL occult blood tests ,FECES ,IMMUNOCHEMISTRY ,HEALTH insurance ,MEDICAID ,MEDICAL care ,MEDICARE ,POSTAL service ,RECTUM tumors ,SEX distribution ,EVALUATION of human services programs ,DESCRIPTIVE statistics ,STATE health plans ,EARLY detection of cancer - Abstract
BeneFIT was a demonstration project that worked with a Medicaid/Medicare health plan to implement a mailed fecal immunochemical test (FIT) program. The goal was to reach age-eligible enrollees who were due for colorectal cancer (CRC) screening and prompt them to complete a FIT. One health insurance plan collaborated with six federally qualified health centers (FQHCs) in Oregon. Reach was defined as the percent of eligible individuals overdue for CRC screening who were mailed a FIT in 2016. We examined patient-level factors associated with reach, using multivariable log binomial regression and FIT completion rates at 6 months. The health plan identified 3386 age-eligible members overdue for CRC screening. Of these, 2615 (77.2%) were reached (mailed FIT kits) and 771 (22.8%) were not; 478 (14.1%) because they were not considered to be clinic patients and 290 (8.6%) because of mailing issues. Patient-level factors associated with not being reached were: being male, being Medicaid-insured (vs. Medicare), and having no primary care visits (vs. 4+ visits) in the last year. Among all enrollees identified as overdue for CRC screening, FIT completion rates at 6 months were 14.8% overall and 18.5% in the subgroup reached. In a mailed FIT program, a health insurance plan attempted to reach as many enrollees overdue for CRC screening as possible, however 22.8% were not mailed a FIT. Additional efforts are needed to ensure that the hardest to reach enrollees can participate in CRC screening. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
5. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.
- Author
-
Coronado, Gloria D., Green, Beverly B., West, Imara I., Schwartz, Malaika R., Coury, Jennifer K., Vollmer, William M., Shapiro, Jean A., Petrik, Amanda F., Baldwin, Laura‐Mae, and Baldwin, Laura-Mae
- Subjects
COLORECTAL cancer ,EARLY detection of cancer ,MEDICAID ,MEDICARE - Abstract
Background: Colorectal cancer screening uptake is low, particularly among individuals enrolled in Medicaid. To the authors' knowledge, little is known regarding the effectiveness of direct-to-member outreach by Medicaid health insurance plans to raise colorectal cancer screening use, nor how best to deliver such outreach.Methods: BeneFIT is a hybrid implementation-effectiveness study of 2 program models that health plans developed for a mailed fecal immunochemical test (FIT) intervention. The programs differed with regard to whether they used a centralized approach (Health Plan Washington) or collaborated with health centers (Health Plan Oregon). The primary implementation outcome of the current study was the percentage of eligible enrollees to whom the plans delivered each intervention component. The primary effectiveness outcome was the rate of FIT completion within 6 months of mailing of the introductory letter.Results: The health plans identified 12,000 eligible enrollees (8551 in Health Plan Washington and 3449 in Health Plan Oregon). Health Plan Washington mailed an introductory letter and FIT kit to 8551 enrollees (100%) and delivered a reminder call to 839 (10.3% of the 8132 attempted). Health Plan Oregon mailed an introductory letter, and a letter and FIT kit plus a reminder postcard to 2812 enrollees (81.5%) and 2650 enrollees (76.8%), respectively. FIT completion rates were 18.2% (1557 of 8551 enrollees) in Health Plan Washington. In Health Plan Oregon, completion rates were 17.4% (488 of 2812 enrollees) among enrollees who were mailed an introductory letter and 18.3% (484 of 2650 enrollees) among enrollees who also were mailed a FIT kit plus reminder postcard.Conclusions: The implementation of mailed FIT outreach by health plans may be effective and could reach many individuals at risk of developing colorectal cancer. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
6. Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program.
- Author
-
Green, Beverly B., Baldwin, Laura-Mae, West, Imara I., Schwartz, Malaika, and Coronado, Gloria D.
- Published
- 2020
- Full Text
- View/download PDF
7. Integrating Primary Care Into Community Mental Health Centers: Impact on Utilization and Costs of Health Care.
- Author
-
Krupski, Antoinette, West, Imara I., Scharf, Deborah M., Hopfenbeck, James, Andrus, Graydon, Joesch, Jutta M., and Snowden, Mark
- Subjects
CARE of people ,PEOPLE with mental illness ,PRIMARY care ,COMMUNITY mental health services ,HOSPITAL admission & discharge ,HOSPITAL costs ,INPATIENT care ,MENTAL illness treatment ,OUTPATIENT medical care ,INTEGRATED health care delivery ,PRIMARY health care ,ECONOMICS - Abstract
Objective: This evaluation was designed to assess the impact of providing integrated primary and mental health care on utilization and costs for outpatient medical, inpatient hospital, and emergency department treatment among persons with serious mental illness.Methods: Two safety-net, community mental health centers that received a Substance Abuse and Mental Health Services Administration Primary and Behavioral Health Care Integration (PBHCI) grant were the focus of this study. Clinic 1 had a ten-year history of providing integrated services whereas clinic 2 began integrated services with the PBHCI grant. Difference-in-differences (DID) analyses were used to compare individuals enrolled in the PBHCI programs (N=373, clinic 1; N=389, clinic 2) with propensity score-matched comparison groups of equal size at each site by using data obtained from medical records.Results: Relative to the comparison groups, a higher proportion of PBHCI clients used outpatient medical services at both sites following program enrollment (p<.003, clinic 1; p<.001, clinic 2). At clinic 1, PBHCI was also associated with a reduction in the proportion of clients with an inpatient hospital admission (p=.04) and a trend for a reduction in inpatient hospital costs per member per month of $217.68 (p=.06). Hospital-related cost savings were not observed for PBHCI clients at clinic 2 nor were there significant differences between emergency department use or costs for PBHCI and comparison groups at either clinic.Conclusions: Investments in PBHCI can improve access to outpatient medical care for persons with severe mental illness and may also curb hospitalizations and associated costs in more established programs. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
8. Utility of Point-of-care Urine Drug Tests in the Treatment of Primary Care Patients With Drug Use Disorders.
- Author
-
McDonell, Michael G., Graves, Meredith C., West, Imara I., Ries, Richard K., Donovan, Dennis M., Bumgardner, Kristin, Krupski, Antoinette, Dunn, Chris, Maynard, Charles, Atkins, David C., and Roy-Byrne, Peter
- Published
- 2016
- Full Text
- View/download PDF
9. Suicide risk and associated demographic and clinical correlates among primary care patients with recent drug use.
- Author
-
Carmel, Adam, Ries, Richard, West, Imara I., Bumgardner, Kristin, and Roy-Byrne, Peter
- Subjects
SUICIDAL behavior ,PRIMARY care ,DRUG abuse ,SUBSTANCE abuse ,ADDICTION Severity Index - Abstract
Background: There is an increased need to prepare primary care clinicians to effectively gauge the risk of suicidal behavior occurring within primary care patients who may abuse drugs, especially those served in safety-net settings.Objectives: The objectives of this paper were to explore suicide risk in a population of individuals endorsing recent drug use, and to describe patient demographic, medical, psychiatric, social, and substance use characteristics across different levels of suicide risk.Methods: A total of 867 primary care patients with reported drug use in the previous 90 days were studied. Based upon their responses to two Addiction Severity Index questions, four suicide risk categories were constructed: (1) low risk; (2) moderate-low (suicidal ideation in the past 30 days); (3) moderate-high (history of a lifetime suicide attempt); and (4) high risk (history of a lifetime suicide attempt and suicidal ideation in the past 30 days). The association between suicide risk groups and demographic and clinical variables were assessed.Results: A total of 40% of primary care patients endorsing recent drug use reported a lifetime suicide attempt. Compared to individuals in other suicide risk groups, individuals at high suicide risk had higher rates of substance use severity, recently used two or more substances, and were more likely to have a comorbid psychiatric condition.Conclusion: These findings indicate that the percentage of patients with suicide risk may be higher among patients with recent drug use. Primary care clinicians should be aware that they may be encountering patients with suicide risk among those with recent drug use. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
10. Drug Use Severity, Mortality, and Cause of Death in Primary Care Patients With Substance Use Disorders.
- Author
-
Maynard, Charles, Graves, Meredith Cook, West, Imara I., Bumgardner, Kristin, Krupski, Antoinette, and Roy-Byrne, Peter
- Published
- 2016
- Full Text
- View/download PDF
11. Chronic Disease and Chemical Dependency Treatment in Primary Care Patients With Problem Drug Use.
- Author
-
Maynard, Charles, Graves, Meredith, West, Imara I., Bumgardner, Kristin, Krupski, Antoinette, and Roy-Byrne, Peter
- Subjects
TREATMENT of drug addiction ,SUBSTANCE abuse treatment ,CHI-squared test ,CHRONIC diseases ,PRIMARY health care ,TIME ,LOGISTIC regression analysis - Abstract
The article discusses a study which examines the link between chemical dependency and chronic disease among primary care patients. The study uses randomized clinical trial, retrospective cohort design, and Chi-square statistic to achieve the study objective. The study reveals the effects of medical condition on drug dependency.
- Published
- 2015
- Full Text
- View/download PDF
12. Are medical marijuana users different from recreational users? The view from primary care.
- Author
-
Roy‐Byrne, Peter, Maynard, Charles, Bumgardner, Kristin, Krupski, Antoinette, Dunn, Chris, West, Imara I., Donovan, Dennis, Atkins, David C., and Ries, Richard
- Subjects
CANNABIS (Genus) ,COMPARATIVE studies ,HEALTH status indicators ,RESEARCH methodology ,MEDICAL cooperation ,PRIMARY health care ,RECREATION ,RESEARCH ,MEDICAL marijuana ,EVALUATION research ,DRUG abusers ,PSYCHOLOGY of drug abusers - Abstract
Background and Objectives: Marijuana is currently approved for medical use in 23 states. Both clinicians and the lay public have questioned whether users of marijuana for medical purposes are different from users of marijuana for recreational purposes. This study examined similarities and differences in important clinical characteristics between users of medical marijuana and users of recreational marijuana.Methods: The sample consisted of 868 adult primary care patients in Washington State, who reported use of medical marijuana (n = 131), recreational marijuana (n = 525), or drugs other than marijuana (n = 212). Retention was over 87% at 3-, 6-, 9-, and 12-month assessments.Results: The majority of medical, psychiatric, substance use, and service utilization characteristic comparisons were not significant. However, medical marijuana users had significantly more medical problems, a significantly larger proportion reported >15 days medical problems in the past month, and significantly smaller proportions reported no pain and no mobility limitations (p < .001). Medical marijuana users also had significantly lower drug problem severity, lower alcohol problem severity, and significantly larger proportions reported using marijuana alone and concomitant opioid use only (p < .001). There was no significant difference between medical and recreational users in the percentage using marijuana with at least two additional substances (48% vs. 58%, respectively, p = .05).Conclusions and Scientific Significance: Although our results suggest that there are few distinct differences between medical and recreational users of marijuana, the differences observed, while mostly very small in effect size (<.2), are consistent with at least some medical users employing marijuana to relieve symptoms and distress associated with medical illness. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
13. Correlates of Opioid Use in Adults With Self-Reported Drug Use Recruited From Public Safety-Net Primary Care Clinics.
- Author
-
Ries, Richard, Krupski, Antoinette, West, Imara I., Maynard, Charles, Bumgardner, Kristin, Donovan, Dennis, Dunn, Chris, and Roy-Byrne, Peter
- Published
- 2015
- Full Text
- View/download PDF
14. A Randomized Controlled Trial of Intensive Care Management for Disabled Medicaid Beneficiaries with High Health Care Costs.
- Author
-
Bell, Janice F., Krupski, Antoinette, Joesch, Jutta M., West, Imara I., Atkins, David C., Court, Beverly, Mancuso, David, and Roy‐Byrne, Peter
- Subjects
CHRONIC diseases ,DISABILITIES ,HEALTH services accessibility ,MEDICAL care use ,CRITICAL care medicine ,MEDICAL care costs ,MANAGEMENT - Abstract
Objective To evaluate outcomes of a registered nurse-led care management intervention for disabled Medicaid beneficiaries with high health care costs. Data Sources/Study Setting Washington State Department of Social and Health Services Client Outcomes Database, 2008-2011. Study Design In a randomized controlled trial with intent-to-treat analysis, outcomes were compared for the intervention ( n = 557) and control groups ( n = 563). A quasi-experimental subanalysis compared outcomes for program participants ( n = 251) and propensity score-matched controls ( n = 251). Data Collection/Extraction Methods Administrative data were linked to describe costs and use of health services, criminal activity, homelessness, and death. Principal Findings In the intent-to-treat analysis, the intervention group had higher odds of outpatient mental health service use and higher prescription drug costs than controls in the postperiod. In the subanalysis, participants had fewer unplanned hospital admissions and lower associated costs; higher prescription drug costs; higher odds of long-term care service use; higher drug/alcohol treatment costs; and lower odds of homelessness. Conclusions We found no health care cost savings for disabled Medicaid beneficiaries randomized to intensive care management. Among participants, care management may have the potential to increase access to needed care, slow growth in the number and therefore cost of unplanned hospitalizations, and prevent homelessness. These findings apply to start-up care management programs targeted at high-cost, high-risk Medicaid populations. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
15. Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial.
- Author
-
Roy-Byrne, Peter, Bumgardner, Kristin, Krupski, Antoinette, Dunn, Chris, Ries, Richard, Donovan, Dennis, West, Imara I, Maynard, Charles, Atkins, David C, Graves, Meredith C, Joesch, Jutta M, and Zarkin, Gary A
- Abstract
Importance: Although brief intervention is effective for reducing problem alcohol use, few data exist on its effectiveness for reducing problem drug use, a common issue in disadvantaged populations seeking care in safety-net medical settings (hospitals and community health clinics serving low-income patients with limited or no insurance).Objective: To determine whether brief intervention improves drug use outcomes compared with enhanced care as usual.Design, Setting, and Participants: A randomized clinical trial with blinded assessments at baseline and at 3, 6, 9, and 12 months conducted in 7 safety-net primary care clinics in Washington State. Of 1621 eligible patients reporting any problem drug use in the past 90 days, 868 consented and were randomized between April 2009 and September 2012. Follow-up participation was more than 87% at all points.Interventions: Participants received a single brief intervention using motivational interviewing, a handout and list of substance abuse resources, and an attempted 10-minute telephone booster within 2 weeks (n = 435) or enhanced care as usual, which included a handout and list of substance abuse resources (n = 433).Main Outcomes and Measures: The primary outcomes were self-reported days of problem drug use in the past 30 days and Addiction Severity Index-Lite (ASI) Drug Use composite score. Secondary outcomes were admission to substance abuse treatment; ASI composite scores for medical, psychiatric, social, and legal domains; emergency department and inpatient hospital admissions, arrests, mortality, and human immunodeficiency virus risk behavior.Results: Mean days used of the most common problem drug at baseline were 14.40 (SD, 11.29) (brief intervention) and 13.25 (SD, 10.69) (enhanced care as usual); at 3 months postintervention, means were 11.87 (SD, 12.13) (brief intervention) and 9.84 (SD, 10.64) (enhanced care as usual) and not significantly different (difference in differences, β = 0.89 [95% CI, -0.49 to 2.26]). Mean ASI Drug Use composite score at baseline was 0.11 (SD, 0.10) (brief intervention) and 0.11 (SD, 0.10) (enhanced care as usual) and at 3 months was 0.10 (SD, 0.09) (brief intervention) and 0.09 (SD, 0.09) (enhanced care as usual) and not significantly different (difference in differences, β = 0.008 [95% CI, -0.006 to 0.021]). During the 12 months following intervention, no significant treatment differences were found for either variable. No significant differences were found for secondary outcomes.Conclusions and Relevance: A one-time brief intervention with attempted telephone booster had no effect on drug use in patients seen in safety-net primary care settings. This finding suggests a need for caution in promoting widespread adoption of this intervention for drug use in primary care.Trial Registration: clinicaltrials.gov Identifier: NCT00877331. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
16. Brief Intervention for Problem Drug Use in Safety-Net Primary Care Settings.
- Author
-
Roy-Byrne, Peter, Bumgardner, Kristin, Krupski, Antoinette, Dunn, Chris, Ries, Richard, Donovan, Dennis, West, Imara I., Maynard, Charles, Atkins, David C., Graves, Meredith C., Joesch, Jutta M., and Zarkin, Gary A.
- Subjects
SHORT-term counseling ,INTERVENTION (Social services) ,DRUG abuse treatment ,SAFETY-net health care providers ,PRIMARY care ,CLINICAL trials ,SUBSTANCE abuse treatment - Abstract
IMPORTANCE Although brief intervention is effective for reducing problem alcohol use, few data exist on its effectiveness for reducing problem drug use, a common issue in disadvantaged populations seeking care in safety-net medical settings (hospitals and community health clinics serving low-income patients with limited or no insurance). OBJECTIVE To determine whether brief intervention improves drug use outcomes compared with enhanced care as usual. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial with blinded assessments at baseline and at 3,6,9, and 12 months conducted in 7 safety-net primary care clinics in Washington State. Of 1621 eligible patients reporting any problem drug use in the past 90 days, 868 consented and were randomized between April 2009 and September 2012. Follow-up participation was more than 87% at all points. INTERVENTIONS Participants received a single brief intervention using motivational interviewing, a handout and list of substance abuse resources, and an attempted 10-minute telephone booster within 2 weeks (n = 435) or enhanced care as usual, which included a handout and list of substance abuse resources (n = 433). MAIN OUTCOMES AND MEASURES The primary outcomes were self-reported days of problem drug use in the past 30 days and Addiction Severity Index-Lite (ASI) Drug Use composite score. Secondary outcomes were admission to substance abuse treatment; ASI composite scores for medical, psychiatric, social, and legal domains; emergency department and inpatient hospital admissions, arrests, mortality, and human immunodeficiency virus risk behavior. RESULTS Mean days used of the most common problem drug at baseline were 14.40 (SD, 11.29) (brief intervention) and 13.25 (SD, 10.69) (enhanced care as usual); at 3 months SD, 10.64) (enhanced care as usual) and not significantly different (difference in differences, β = 0.89 [95% Cl, -0.49 to 2.26]). Mean ASI Drug Use composite score at baseline was 0.11 (SD, 0.10) (brief intervention) and 0.11 (SD, 0.10) (enhanced care as usual) and at 3 months was 0.10 (SD, 0.09) (brief intervention) and 0.09 (SD, 0.09) (enhanced care as usual) and not significantly different (difference in differences, β = 0.008 [95% Cl, -0.00 6 to 0.021]). During the 12 months following intervention, no significant treatment differences were found for either variable. No significant differences were found for secondary outcomes. CONCLUSIONS AND RELEVANCE A one-time brief intervention with attempted telephone booster had no effect on drug use in patients seen in safety-net primary care settings. This finding suggests a need for caution in promoting widespread adoption o f this intervention for drug use in primary care. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
17. Interdisciplinary Craniofacial Teams Compared With Individual Providers: Is Orofacial Cleft Care More Comprehensive and Do Parents Perceive Better Outcomes?
- Author
-
Austin, April A., Druschel, Charlotte M., Tyler, Margaret C., Romitti, Paul A., West, Imara I., Damiano, Peter C., Robbins, James M., and Burnett, Whitney
- Subjects
CHILD care ,AESTHETICS ,CLEFT palate children ,HUMAN abnormalities ,PEDIATRICS - Abstract
Objective: The primary objective was to examine whether children with orofacial clefts received more comprehensive care and whether their parents perceived better outcomes if the care was delivered by interdisciplinary teams compared with individual providers. Design: Data about services received and outcomes were collected from mothers of children with orofacial clefts. Participants: Mothers of children born between 1998 and 2003 with orofacial clefts from Arkansas, Iowa, and New York who participated in the National Birth Defects Prevention Study were eligible. Main Outcome Measure(s): Services and treatments received and maternal perception of cleft care, health status, aesthetics, and speech were evaluated by team care status. Results: Of 253 children, 24% were not receiving team care. Of those with cleft lip and palate,86% were enrolled in team care. Compared with children with team care, those without had fewer surgeries and were less likely to have seen a dentist, received a hearing test, or had a genetic consultation. Mothers of children lacking team care were twice as likely to give lower ratings for overall cleft care; maternal perceptions of global health, facial appearance, and speech did not differ by team care status. Conclusions: Recommended care tended to be received more often among those with team care. A larger, longitudinal study might answer questions about whether team care provides the best care and the role that type and severity of the condition and racial/ethnic differences play in the services received and outcomes experienced. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
18. Response to Urine Drug Testing in a Family Residency Practice.
- Author
-
West, Imara I., Ries, Richard K., Donovan, Dennis M., Bumgardner, Kristin, Dunn, Chris, Atkins, David C., Roy-Byrne, Peter, and Maynard, Charles
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.